A systematic review and meta-analysis of propofol versus midazolam sedation in adult intensive care (ICU) patients

Purpose: Compare outcomes of adult patients admitted to ICU-length of ICU stay, length of mechanical ventila-tion (MV), and time until extubation-according to the use of propofol versus midazolam. Methods: We searched MEDLINE, EMBASE, LILACS, and Cochrane databases to retrieve RCTs that compared propofol and midazolam used as sedatives in adult ICU patients. We applied a random-effects, meta-analytic model in all calculations. We applied the Cochrane collaboration tool and GRADE. We separated patients into two groups: acute surgical patients (hospitalization up to 24 h) and critically-ill patients (hospitalization over 24 h and whose articles mostly mix surgical, medical and trauma patients). Results: Globally, propofol was associated with a reduced MV time of 4.46 h (MD:-4.46 [95% CI-7.51 to -1.42] p = 0.004, I2 = 63%, 6 studies) and extubation time of 7.95 h (MD:-7.95 [95% CI-9.86 to -6.03] p < 0.00001, I2 = 98%, 16 studies). Acute surgical patients sedation with propofol compared to midazolam was associated with a reduced ICU stay of 5.07 h (MD:-5.07 [95% CI-8.68 to -1.45] p = 0.006, I2 = 41%, 5 studies), MV time of 4.28 h (MD: -4.28; [95% CI-4.62 to -3.94] p < 0.0001, I2 = 0%, 3 studies), extubation time of 1.92 h (MD: - 1.92; [95% CI-2.71 to -1.13] p = 0.00001, I2 = 89%, 9 studies). In critically-ill patients sedation with propofol compared to midazolam was associated with a reduced extubation time of 32.68 h (MD:-32.68 [95% CI-48.37 to - 16.98] p = 0.0001, I2 = 97%, 9 studies). GRADE was very low for all outcomes. Conclusions: Sedation with propofol compared to midazolam is associated with improved clinical outcomes in ICU, with reduced ICU stay MV time and extubation time in acute surgical patients and reduced extubation time in critically-ill patients. (c) 2021 Elsevier Inc. All rights reserved.